FEATURED ARTICLES

• Reinventing Prostate Cancer Diagnostics With An All-In-One Platform

  Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

• From Months To Hours: MMC Medical's EDC Revolution

  Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

• Executing Concurrent Decentralized RCTs And RWE At Scale

  See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

• 3-Week Database Builds That Withstood FDA Review

  Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.

• The Patient Experience Paradox: eCOA Strategy Overhaul

  European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.

• Implications Of Assessing Overall Survival In Oncology Studies

  New oncology standards mandate pre-specified survival analysis to catch long-term harm. Learn how to implement hazard ratio thresholds and the ICH E9(R1) framework for global compliance.

• The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More

  High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.

• The End Of The "PRO Tax": Top 10 Commercial PROs & Their Cost-Effective Alternatives

  Regulators now prioritize fit-for-purpose data over legacy instrument brand names. Modernizing your assessment strategy reduces licensing delays and improves trial startup speed and efficiency.

• Is Your eCOA UAT Stuck In Time?

  Bridge the gap between complex trial schedules and short testing cycles. Explore how automated validation protects data integrity and prevents costly mid-study corrections.

• On-Site ePRO In Action

  Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.

• ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs

  ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.

• Offline eCOA: The Real-Time Monitoring Dilemma

  Balance the need for offline data safety with the necessity of real-time monitoring. Learn how to navigate new regulatory requirements for source devices while maintaining high patient compliance.

• Global e-Consent Matrix

  Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.

• The Real Cost In CNS Trials: Rater Drift And Site Readiness

  Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.

• ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations

  Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.

• Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials

  This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.

• The EMR Interoperability Dream Vs. Clinical Research Reality

  Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.

• Automated Evidence Generation For Regulatory-Grade RWD

  Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.

• The New Standard In Participant-Centric Trials

  Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.

• Patient-Focused Data Capture For Cancer Research

  In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.